Clinical Trial Update: Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of pegamotecan in advanced or metastatic soft tissue sarcoma has been suspended. Enrollment and ongoing conduct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Pegamotecan (pegamotecan)

Snippet

Sponsor: Enzon Pharmaceuticals, Inc. | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: SUSPENDED